Global oncology R&D continues to expand, bringing exciting new treatment options to patients. Seventy percent of the R&D pipeline is driven by the innovation of biotech companies. This creates immense pressure to deliver novel treatments and secure investor funding in a highly complex environment.

Join this webinar to hear from experts with the IQVIA Institute and IQVIA Biotech about global oncology trends impacting sponsors and how to optimize clinical trial strategy.

Key Learning Objectives

• Evaluate findings from the 2023 Global Oncology Trends report significant to biotech sponsors
• Explore nuances of early phase oncology trial design and strategy
• Understand considerations for platform design trials to help increase accessibility to new treatment options
• Review progress made to improve representation of race and ethnicity in clinical trial subjects; learn how to build diversity planning in clinical trial protocols

Speakers:

Murray Aitken
Executive Director
IQVIA Institute for Human Data Science

Gerhard Du Toit
Global Oncology Head
IQVIA Biotech